ArticleJournal of medical ultrasound
Thyroid Nodule Size is Not a Predictor of Malignancy: A Focus on Fine-needle Aspiration Cytology Findings.
Article in Journal of medical ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aimed to evaluate the relationship between thyroid nodule size and various factors and malignancy risk, using fine-needle aspiration cytology (FNAc) as the diagnostic standard. Methods: A retrospective analysis was conducted on 760 patients with 850 thyroid nodules who underwent ultrasound (US) and US-guided FNAc from June 2023 to July 2024. Nodules were assessed using the ACR-Thyroid Imaging Reporting and Data Systems (TIRADS) classification and classified cytologically according to the 2017 Bethesda System. Statistical analyses included logistic regression to evaluate the association between variables and malignancy risk. Results: Malignant nodules were predominantly observed in TIRADS category 5 (72.7%), while benign nodules were more frequent in categories 3 and 4. Higher TIRADS scores were significantly associated with malignancy, each unit increase in score was associated with a 5.86 - fold increase in odds ( Conclusion: TIRADS is an effective tool for predicting thyroid malignancy and stratifying risk, aiding clinical decision-making. Younger age is a significant risk factor, while nodule size alone should not be used as a predictor of malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.